Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on ROCHE HOLDING LTD.
02/24 ROCHE : Presolicitation Notice - 1 year service & support contract for two Roche..
02/23 ROCHE : European Commission conditionally approves Roches cancer drug Alecensa
02/23 ROCHE : You 'cannot hang on to' breast cancer drug, high court tells roche
02/22 FOUNDATION MEDICINE : reports 4Q loss
02/22 FOUNDATION MEDICINE, INC. : Results of Operations and Financial Condition, Finan..
02/22 ROCHE : TAC Calls for Roche to Drop Price of Cancer Drug
02/22 CHUGAI PHARMACEUTICAL : ALK Inhibitor 'Alecensa' Approved in the EUAlecensa is A..
02/22 ROCHE : Registration closing soon for 11th annual Paediatric Clinical Trials sho..
02/21 ROCHE : Enters Hematology Market with Integrated Analyzer
02/21 ROCHE : receives EU approval of Alecensa (alectinib) for people with previously ..
02/20 ROCHE : Global Histology Equipment Market- Leica, Roche, Sakura Finetek, Thermo ..
02/20 CHUGAI PHARMACEUTICAL : New Drug Application Filed for Immune Checkpoint Inhibit..
02/20 ROCHE : Phase II study supports potential for Roche's TECENTRIQ (atezolizumab) p..
02/19 ROCHE : College basketball
02/18 ROCHE : Phase II study supports potential for Roche’s TECENTRIQ (atezolizu..
02/18 ROCHE : Phase II Study Supports Potential for Genentech’s Tecentriq® (Atez..
02/17DJROCHE : U.S. Obtains Records in Lobbyist Probe -- WSJ
02/17DJROCHE : FBI Searches for Possible Accomplices in Probe of Fallen K Street Lobbyi..
02/16 ROCHE : Federal Contracts Awarded by Federal Agencies in Louisiana (Feb. 16)
02/16 ROCHE : $188,290 Federal Contract Awarded to Roche Diagnostics
02/15 ROCHE : ISN moves to help diabetic patients in Nigeria
02/14 ROCHE : Good News about CAPSLO and Kids' Cancer Research Foundation
02/14 ROCHE : Sources Sought Notice - Reagents and consumables for Ventana Medical Sys..
02/14 ROCHE : Cancer Survivor and Noted Physician-Scientist Sandra Horning to Receive ..
02/12 ROCHE : College basketball
02/10 ROCHE : under fire for cost of cancer meds
02/08 FOUNDATION MEDICINE : FMI) Spikes Following Tuesday
02/08 ROCHE : Supply and maintenance of software for accounting
02/07 ROCHE : $31,820 Federal Contract Awarded to Roche Diagnostics
02/07 ROCHE : Construction of two bunkers b5 and b7
02/04 ROCHE : $31,817 Federal Contract Awarded to Roche Diagnostics
02/02 Seven Bridges to Present on Cancer Moonshot's Blood Profiling Atlas at Precis..
02/02DJSIEMENS : CEO Frets About America -- WSJ
02/01 BELLICUM PHARMACEUTICALS : Announces Appointment of Rick Fair as Chief Executive..
02/01DJROCHE : Unfazed by Trump's Drug-Price Comments as Profit Rises -- 3rd Update
02/01 ROCHE : $300,757 Federal Contract Awarded to Roche Diagnostics
02/01DJROCHE : Unfazed by Trump's Drug-Price Comments as Profit Rises -- 2nd Update
02/01DJROCHE : Profit Lifted by Drug, Diagnostic-Tool Sales -- Update
02/01DJROCHE : Profit Lifted by Drug, Diagnostic Tool Sales
01/31 CHUGAI PHARMACEUTICAL : Wins the Grand Prize for the Second Consecutive Year in ..
01/30 ROCHE : Ministry of Health and Prevention joins hands with Swiss company in figh..
01/30 ROCHE : Supply of chemicals
01/28 JUNO THERAPEUTICS : Appoints Corsee D. Sanders as Executive Vice President and H..
01/27ROCHE HOLDING LTD. : annual earnings release
01/26 ROCHE : Les autorités ont lancé un projet d’accréditation de centres de re..
01/26DJBRISTOL MYERS SQUIBB : Cuts Guidance on Cancer Drug Problems--Update
01/26 CHUGAI PHARMACEUTICAL : Aiming to Provide Solutions that Meet Changes of Regiona..
01/26 CHUGAI PHARMACEUTICAL : - Personnel Changes
01/25 REMINDER : Invitation to Roche's Full Year Results 2016
01/25 ROCHE : FDA Grants Priority Review For Genentech's Actemra (Tocilizumab) Supplem..
01/25 NOVARTIS CEO : "The bigger the target, the higher the premium"
01/24 ROCHE : FDA Grants Priority Review for Genentech’s Actemra® (Tocilizumab) ..
01/24 ROCHE : FDA grants priority review for Roche’s Actemra/RoActemra (tocilizu..
01/23 Agenda Out for Pharmaceutical Freeze Drying 2017 Summit Featuring Pfizer, Boe..
01/21 Agenda Released for Pharmaceutical Freeze Drying 2017 Summit Featuring Pfizer..
01/20 Bristol-Myers shares fall on lung cancer timeline setback
01/20 ROCHE : Breakthrough development for Americans with suspected heart attack - Nex..
01/20 ROCHE : Presolicitation Notice - Purchase of Roche Filter Tips
01/20 FOUNDATION MEDICINE INC. : (FMI) CFO Jason Ryan Sells 1,777 Shares of Stock
01/20 INSIDER SELLING : Foundation Medicine, Inc. (FMI) CFO Sells 1,777 Shares of Stoc..
01/19 FOUNDATION MEDICINE : Announces Executive Leadership Transition
01/19 EXELIXIS : Update on Dispute between Exelixis and Genentech, a Member of the Roc..
01/19 GSK grabs Astra executive to replace pharma head
01/19 EISAI : acquires manufacturing rights for API from Roche to treat insomnia
01/19 ROCHE : Extended FDA Review for Lilly/Incyte's Olumiant (baricitinib) in Rheumat..
01/18 Global Influenza Market Has Been Accelerated USD 6.87 Billion in 2020
01/18 ROCHE : FDA Grants Genentech's Cancer Immunotherapy Tecentriq (Atezolizumab) Pri..
01/18 Drugmakers in Davos shift focus to chronic diseases of poor
01/17 ROCHE : Multiplex System Addresses IHC Needs
01/16 Global Lycopene Market 2017 - DSM, BASF, NIPPON, Kagome, Bayer, KIRIN, Roche ..
01/13 ROCHE : Johnson & Johnson and Alstrom Syndrome UK Address Hot Topic of Paediatri..
01/12 FOUNDATION MEDICINE : to Present at the 35th Annual J.P. Morgan Healthcare Confe..
01/12 PTC THERAPEUTICS : Announces Initiation of FIREFISH Study in Infant Type I SMA P..
01/12 CHUGAI PHARMACEUTICAL : Reports Outline Peptide Receptors Study Findings from Ch..
01/12 KITE PHARMA : Enhances Commercial Expertise with the Appointment of Ian T. Clark..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ( CHF)
Sales 2017 53 280 M
EBIT 2017 18 459 M
Net income 2017 11 591 M
Debt 2017 9 128 M
Yield 2017 3,53%
P/E ratio 2017 18,07
P/E ratio 2018 16,75
EV / Sales 2017 4,14x
EV / Sales 2018 3,83x
Capitalization 211 194 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 279  CHF
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Alan Hippe Chief Financial & Information Technology Officer
John Irving Bell Non-Executive Director
Andreas Oeri Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.209 906
JOHNSON & JOHNSON5.63%331 089
ROCHE HOLDING LTD.5.98%209 906
PFIZER INC.4.86%206 688
NOVARTIS AG4.72%201 806
MERCK & CO., INC.11.86%181 558
More Results